SCA
BLFS icon

Spearhead Capital Advisors’s BioLife Solutions BLFS Stock Holding History

Spearhead Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,374
Closed -$213K – 182
2022
Q1 		$213K Sell
9,374
-1,851
-16% -$48.7K 0.03% 183
2021
Q4 		$418K Buy
11,225
+112
+1% +$4.81K 0.05% 112
2021
Q3 		$470K Sell
11,113
-45
-0.4% -$2.17K 0.06% 106
2021
Q2 		$497K Buy
11,158
+1,516
+16% +$53.4K 0.07% 100
2021
Q1 		$347K Buy
+9,642
New +$381K 0.05% 126

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Spearhead Capital Advisors's BLFS Position: Q2 2022 in Review

Spearhead Capital Advisors sold out of BioLife Solutions (BLFS) in Q2 2022, closing a stake of 9,374 shares — an estimated $213K sold.

Spearhead Capital Advisors first reported a position in BLFS in Q1 2021 and held it in 5 quarters. The position peaked at $497K in Q2 2021. 160 funds tracked by Wall St. Rank hold BLFS as of Q2 2022.

  • Spearhead Capital Advisors reported no remaining BioLife Solutions position as of Q2 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 9,374 BioLife Solutions shares in Q2 2022, an estimated $213K.
  • Spearhead Capital Advisors first reported a position in BioLife Solutions in Q1 2021 and held it in 5 quarters.
  • Spearhead Capital Advisors's BioLife Solutions position peaked at $497K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2022.

Based on Spearhead Capital Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.